Asia Pacific Newborn Screening Market is Progressing Towards a Strong Growth By 2026

1. Asia Pacific Newborn Screening Asia Pacific Newborn Screening Market Size, Share, Trend, Outlook, Future Growth Share, Trend, Outlook, Future Growth Analysis And Synthesis 2018 - 2026 Analysis And Synthesis 2018 - 2026 Market Size, Infants are most vulnerable to diseases such as polio, epilepsy, encephaliphitis, asthma, COPD and other respiratory disease, diarrhea, leukemia, anemia, and other rare diseases that results in substantial economic burden. Newborn screening describes various tests that are performed during first few hours or days of an infant’s life. These tests have the potential of preventing severe health problems and prevents from death. According to American Academy of Pediatrics: 2018, newborn screening and diagnosis are important to ensure that all babies who are deaf or hard of hearing are identified as soon as possible. According to same source, 1 to 3 out of every 1,000 babies born in the U.S. have hearing level outside the typical range. When these babies receive early intervention services, it makes a big difference in their communication and language development in the future. Asia Pacific newborn screening market size was valued at US$ 171.3 million in 2017 and is expected to Asia Pacific newborn screening market size was valued at US$ 171.3 million in 2017 and is expected to witness a CAGR of 12.7% during the forecast period (2018 – 2026). witness a CAGR of 12.7% during the forecast period (2018 – 2026). Get PDF Brochure of Research Report: Get PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/2546 https://www.coherentmarketinsights.com/insight/request-pdf/2546 Increasing government initiatives is expected to drive growth of the Asia Pacific newborn screening Increasing government initiatives is expected to drive growth of the Asia Pacific newborn screening market market Increasing engagement programs by various government healthcare regulatory bodies for newborn screening and its deployment for wider population base are expected to drive growth of the market during the forecast period. For instance, in June 2014, PerkinElmer, a company engaged in the diagnostics, life science research, food, environmental and industrial testing area, entered into an exclusive collaboration with China's National Health and Family Planning Commission (NHFPC) to implement a three-year training program for newborn screening.

2. The National Maternal & Children Health Surveillance Office (NMCHSO) is working with PerkinElmer, to increase availability and adoption of newborn screening in China, particularly via expansion in more rural areas. Asia Pacific Newborn Screening Market- Country Analysis Asia Pacific Newborn Screening Market- Country Analysis On the basis of country, Asia Pacific newborn screening market is segmented into China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific. China holds the major share due to innovative and new initiatives by government for implementing various newborn screening programs. Currently Congenital Hypothyroidism (CH) and Phenylketonuria (PKU) and hearing loss are included as national wide screening program in China, which is also mandatory for all newborn. Report includes chapters which deeply display the following deliverable about industry : Report includes chapters which deeply display the following deliverable about industry : • Cardiovascular Drugs Market Research Objective and Assumption • Cardiovascular Drugs Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Cardiovascular Drugs Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Cardiovascular Drugs Market, By Regions • Cardiovascular Drugs Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Cardiovascular Drugs Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Cardiovascular Drugs Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Cardiovascular Drugs Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion

3. Asia Pacific Newborn Screening Market- Competitive Landscape Asia Pacific Newborn Screening Market- Competitive Landscape Key players operating in the Asia Pacific newborn screening market include Medtronic plc, Agilent Technologies, Waters Technologies Corporation, AB SCIEX, Bio-Rad Laboratories, Covidien PLC, GE Life Sciences, Masimo Corporation, Natus Medical Inc., PerkinElmer Inc., Trivitron Healthcare Pvt. Ltd., and ZenTech S.A. Detailed Segmentation: Detailed Segmentation: Asia Pacific Newborn Screening Market, By Product Type: Asia Pacific Newborn Screening Market, By Product Type: Hearing Screening Devices • Mass Spectrometer • Pulse Oximetry • Assay Kits and Reagents • Asia Pacific Newborn Screening Market, By Test Type: Asia Pacific Newborn Screening Market, By Test Type: Phenylketonuria (PKU) • Critical Congenital Heart Defect (CCHD) • Hearing Screening • Sickle Cell Disease • Maple Syrup Urine Disease (MSUD) • Thyroid Disorder • Biotinidase Deficiency (BTD) • Others • Browse In-Depth Analysis Research Report: Browse In-Depth Analysis Research Report: https://www.coherentmarketinsights.com/market- https://www.coherentmarketinsights.com/market- insight/asia-pacific-newborn-screening-market-2546 insight/asia-pacific-newborn-screening-market-2546

4. About Coherent Market Insights About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action- ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: Email: sales@coherentmarketinsights.com sales@coherentmarketinsights.com